DOCSLIB.ORG

Human Nutrition

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Human Nutrition Human Nutrition The range and assurance manufacturers need Partnering with the best For over 20 years we have helped our clients meet exacting Celtic Chemicals exclusively distributes Jost Chemical Co’s requirements in the manufacture of supplements for human renowned range of high purity specialty mineral salts throughout consumption. the UK and Ireland. Our clients rely on us to stock a full range of minerals at all times Our partnership with Jost is long-standing and our customers and are confident that our operations remain fully compliant benefit from Jost’s ability to provide the highest levels of purity with changing industry regulations. and lot-to-lot consistency. As well as consistently delivering product excellence, we Products are made under bulk pharmaceutical cGMP’s and welcome customer audits of our sites and processes at any time. regulated by the US FDA with stocks held at Celtic Chemicals’ onsite facilities. The high purity Jost products we offer are complemented by products from approved food manufacturing sites around the globe and together these provide an ideal range of organic & inorganic acid mineral salts to help our customers’ formulations and product development. The Raw Materials 20 24 29 53 26 12 25 42 34 30 Ca Cr Cu I Fe Mg Mn Mo Se Zn Calcium Chromium Copper Iodine Iron Magnesium Manganese Molybdenum Selenium Zinc Quality Matters Working within UK/EU regulations Our focus is on assisting customers as they adhere to the Food Supplements Directive UK/EU 2002/46/EC and its amendments. The requirements of EC 1881/2006 - and its amendments EC 629/2008 - set the maximum levels for certain contaminants in foodstuffs, notably Lead, Cadmium and Mercury. Arsenic is also controlled through the Food Safety Act. Working outside of the UK/EU We also provide advice for customers interested in sourcing and working with raw materials that are suitable for use outside of the UK/EU. The Process You can rely on our team to work with you to assess your precise requirements and help advise on issues such as solubility and mineral content. A sample for your evaluation, with full documentation, can also be provided on request. Celtic Chemicals Ltd, Unit 25, +44 (0) 1656 749 358 Kenfig Industrial Estate, Margam, +44 (0) 1656 746 490 Port Talbot, SA13 2PE, UK. [email protected] Human Nutrition 20 Calcium Products 12 Magnesium Products Calcium Acetate Pure Magnesium Ascorbate Ca Calcium Carbonate (Light & Heavy) Mg Magnesium Carbonate (Light, Medium & Heavy) Calcium Calcium Chloride 2 Hydrate Magnesium Magnesium Chloride 6 Hydrate Calcium Citrate 4 Hydrate Fine Granular F.C.C. Magnesium Citrate Tribasic Anhydrous U.S.P. Granular Calcium Fumarate Purified Granular Magnesium Gluconate Hydrated (Powder & Granular) Calcium Gluconate 1 Hydrate Magnesium Glycerophosphate Powder Calcium Glycerophosphate Magnesium Glycinate Calcium Hydroxide FCC, Low Aluminium Powder Magnesium Hydroxide Calcium Iodate Anhydrous Magnesium Lactate (2 Hydrate & Anhydrous) Calcium L-Methylfolate Magnesium Malate 3 Hydrate Pure Calcium Lactate 5 Hydrate Magnesium Oxide (Light, Heavy & Granular) Calcium Malate Anhydrous Powder Magnesium Phosphate (Di, Tri, Powder & Granular) Calcium Phosphate (Di, Tri, Anhydrous & Dihydrate) Magnesium Sulphate (7 Hydrate, Dried & Anhydrous) Calcium Pidolate Calcium Succinate 1 Hydrate 25 Manganese Products Manganese Ascorbate Choline Products Mn Manganese Gluconate 2 Hydrate (Powder & Granular) Choline Chloride Manganese C5H14NO Manganese Glycerophosphate Choline L Bitartrate Manganese Glycinate Choline Choline Dihydrogen Citrate Manganese Lactate 3 Hydrate Crystal Manganese Sulphate 1 Hydrate (Powder, Granular & Fine Powder) Chromium Products 24 Tri Manganese Citrate 10 Hydrate Powder Chromium Chloride 6 Hydrate Cr Chromium Chloride on Maltodextrin Chromium Chromium Chloride Solution 42 Molybdenum Products Chromium Picolinate Ammonium Molybdate 4 H20 Chromium Polynicotinate Mo Sodium Molybdate 2 H2O Chromium Polynicotinate Liquid Molybdenum Sodium Molybdate on Maltodextrin Chromium Sulphate 4-Hydrate Selenium Products Copper Products 34 29 L Selenomethionine 40% Se Copper Glycinate Se L Selenomethionine on Di Calcium Phosphate Cu Cupric Carbonate Selenium Potassium Selenate Anhydrous Copper Cupric Citrate Hemitrihydrate Sodium Selenate Anhydrous Cupric Gluconate U.S.P. XXIII Powder Sodium Selenite Anhydrous Cupric Sulphate 5 Hydrate Sodium Selenate on Maltodextrin Cupric Sulphate Anhydrous Sodium Selenite on Maltodextrin Iodine Products 53 Zinc Products Iodine Ph Eur 30 Zinc Acetate 2 Hydrate I Potassium Iodate Zn Zinc Ascorbate 15% Iodine Potassium Iodide Zinc Zinc Asparate 3H2O Potassium Iodide on Maltodextrin Zinc Carbonate Potassium Iodate on Maltodextrin Zinc Chloride Anhydrous Sodium Iodide Zinc Citrate 2 Hydrate (Di, Tri, Powder & Granular) Zinc Citrate 3 Hydrate 26 Iron Products Zinc Gluconate (Powder & Granular) Ammonium Ferric Citrate Powder (Brown, Green & Red) Zinc Glycinate Fe Ferric Citrate Hydrated Zinc Lactate 2 Hydrate (Powder & Granular) Iron Ferric Pyrophosphate FCC 24-26% Fe Zinc Oxide Ferrous Citrate Dibasic Zinc Picolinate Ferrous Fumarate Powder U.S.P./F.C.C./Ph Eur Zinc Sulphate (1 Hydrate & 7 Hydrate) Ferrous Gluconate (Powder & Granular) Ferrous Glycinate Mineral Blends Ferrous Lactate 2 Hydrate (Powder & Granular) 1 Sodium Selenate / Selenite on Maltodextrin Ferrous Sulphate 7 Hydrate % Chromium Chloride on Maltodextrin Ferrous Sulphate, Dried Blends Potassium Iodate / Iodide on Maltodextrin Sodium Molybdate on Maltodextrin L Selenomethionine on Di Calcium Phosphate Alternative carriers available on request..
Load more

Recommended publications
  • Sodium Selenate Hazard Summary Identification
    Common Name: SODIUM SELENATE CAS Number: 13410-01-0 RTK Substance number: 1726 DOT Number: UN 2630 Date: November 2001 ------------------------------------------------------------------------- ------------------------------------------------------------------------- HAZARD SUMMARY WORKPLACE EXPOSURE LIMITS * Sodium Selenate can affect you when breathed in and The following exposure limits are for Selenium compounds may be absorbed through the skin. (measured as Selenium): * Contact can irritate the skin and eyes. * Breathing Sodium Selenate can irritate the nose, throat OSHA: The legal airborne permissible exposure limit 3 and lungs causing coughing, wheezing and/or shortness of (PEL) is 0.2 mg/m averaged over an 8-hour breath. workshift. * High exposure can cause headache, nausea, vomiting, NIOSH: The recommended airborne exposure limit is coated tongue, metallic taste and garlic odor on the breath. 3 * Repeated exposure can cause pallor, nervousness and 0.2 mg/m averaged over a 10-hour workshift. mood changes. ACGIH: The recommended airborne exposure limit is * Sodium Selenate may damage the liver and kidneys and 3 affect the heart. 0.2 mg/m averaged over an 8-hour workshift. * The above exposure limits are for air levels only. When IDENTIFICATION skin contact also occurs, you may be overexposed, even Sodium Selenate is a white, sand-like solid. It is used as a though air levels are less than the limits listed above. medication and an insecticide. WAYS OF REDUCING EXPOSURE REASON FOR CITATION * Where possible, enclose operations and use local exhaust * Sodium Selenate is on the Hazardous Substance List ventilation at the site of chemical release. If local exhaust because it is regulated by OSHA and cited by ACGIH, ventilation or enclosure is not used, respirators should be DOT, NIOSH, DEP and EPA.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,211,656 B2 Mukerji Et Al
    US00721 1656B2 (12) United States Patent (10) Patent No.: US 7,211,656 B2 Mukerji et al. (45) Date of Patent: May 1, 2007 (54) DESATURASE GENES, ENZYMES ENCODED Doerks et al., TIG 14(6): 248-250, Jun. 1998.* THEREBY, AND USES THEREOF Smith et al. Nature Biotechnology 15: 1222-1223, Nov. 15, 1997.* Brenner, S.E., TIG 15(4): 132-133, Apr. 1999.* (75) Inventors: Pradip Mukerji, Gahanna, OH (US); Bork et al., TIG 12(10): 425-427, Oct. 1996.* Suzette L. Pereira, Westerville, OH Leslie, C. G. et al., “Dietary (n-9) Eicosatrienoic Acid from a (US); Yung-Sheng Huang, Upper Cultured Fungus Inhibits Leukotriene B4 Synthesis in Rats and the Arlington, OH (US) Effect Is Modified by Dietary Linoleic Acid' ', Amer Journ of Clin Nutrit, 126(6): 1534-1540 (1996). Jareonkitmongkol, S., et al., “Production of an Eicosapentaenoic (73) Assignee: Abbott Laboratories, Abbott Park, IL Acid-Containing Oil by a A12 Desaturase-Defective Mutant of (US) Mortierella alpina 1S-4”, Journ of the Amer Oil Chemists Soc. 70(2): 119-123 (1993). (*) Notice: Subject to any disclaimer, the term of this Pereira, S.L., et al., “A novel (p-fatty acid desaturase involved in the patent is extended or adjusted under 35 biosynthesis of eicosapentaenoic acid”. The Biohem Journ, U.S.C. 154(b) by 444 days. 378(2):665-671 (2004). Ziboh, V.A., et al., Metabolism of polyunsaturated fatty acids by (21) Appl. No.: 10/060,793 skin epidermal enzymes: generation of anti-inflammatory and antiproliferative metabolites 1-3, Amer Journ of Clin Nutri, (22) Filed: Jan.
    [Show full text]
  • Felix Ekness
    ABSTRACT A Synthetic Biology Approach to Engineering Bacterial Two- Component Systems for Sensor Development and Discovery of Anti-Virulence Agents by Felix Ekness Bacterial two-component systems (TCSs) are the largest family of signal transduction pathways that enable bacteria to sense a diversity of stimuli including small peptides, environmental pollutants, and light. Canonical TCSs are composed of a transmembrane sensor histidine kinase (SK) that converts stimulus detection into phosphorylation of a cognate response regulator (RR). Upon phosphorylation, the cytoplasmic RR binds target output promoters, hereby modulating gene expression. TCSs are valuable sensors for synthetic biology due to their diverse sensing capabilities and straightforward transduction of detected stimulus into transcriptional regulation. TCSs are also emerging targets for novel therapeutic development due to their extensive role in regulating bacterial virulence and antibiotic resistance. Although TCSs are exciting sensors for synthetic biology and targets for therapeutic applications, most TCSs remain difficult to harness for applications and study due to output promoters that are unknown, subject to cross- regulation, or silent in heterologous hosts. In the first portion of my work, I develop a method to overcome the hurdles in characterizing and utilizing TCSs as biosensors. Through the framework of synthetic biology, I demonstrate that the two largest families of RR DNA binding domains (DBDs) can be interchanged with remarkable flexibility, enabling the corresponding TCSs to be rewired to synthetic output promoters. In collaboration with Kristina Daeffler, we exploit this plasticity to eliminate cross-regulation and in collaboration with Brian Landry, we un-silence a gram-negative TCS in a gram-positive host and engineer a sensor with over 1,300-fold activation.
    [Show full text]
  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
    MTC eHealth DSI [eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01
    [Show full text]
  • Antidepressant Effect of ß-Hydroxy-ß-Methylbutyrate
    (19) TZZ Z_T (11) EP 2 745 708 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 25.06.2014 Bulletin 2014/26 A23L 1/305 (2006.01) A23L 1/29 (2006.01) A61K 31/19 (2006.01) A61P 25/24 (2006.01) (21) Application number: 12382531.7 (22) Date of filing: 24.12.2012 (84) Designated Contracting States: • Barranco-Pérez, Alejandro AL AT BE BG CH CY CZ DE DK EE ES FI FR GB 18110 LAS GABIAS (Granada) (ES) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • Rueda Cabrera, Ricardo PL PT RO RS SE SI SK SM TR 18008 GRANADA (ES) Designated Extension States: • Bespalov, Anton BA ME 69118 HEIDELBERG (DE) • Behl, Berthold (71) Applicant: Abbott Laboratories, Inc. 67098 BAD DUERKHEIM (DE) Abbott Park, IL 60064 (US) • Van Gaalen, Marcel M. 67433 NEUSTADT AN DER WEINSTRASSE (DE) (72) Inventors: • Ramírez, María (74) Representative: Ungria López, Javier 18003 GRANADA (ES) Avda. Ramón y Cajal, 78 28043 Madrid (ES) (54) Antidepressant effect of ß-hydroxy-ß-methylbutyrate (57) A method of treating or preventing depression method of treating or preventing a condition which can using β-hydroxy-β-methylbutyrate (HMB) is described. be improved or prevented by the activation of mTOR sig- The method includes administering an effective amount naling by administering an effective amount of HMB or a of HMB or a pharmaceutically acceptable salt thereof to pharmaceutically acceptable salt thereof to a subject in a subject in need thereof. The HMB can be administered need thereof. as part of a nutritional composition.
    [Show full text]
  • Investigation Into the Effect on Structure of Oxoanion Doping in Na2m(SO4)2·2H2O Driscoll, Laura; Wright, Adrian; Kendrick, Emma; Slater, Peter
    University of Birmingham Investigation into the effect on structure of oxoanion doping in Na2M(SO4)2·2H2O Driscoll, Laura; Wright, Adrian; Kendrick, Emma; Slater, Peter DOI: 10.1016/j.jssc.2016.07.004 License: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) Document Version Peer reviewed version Citation for published version (Harvard): Driscoll, L, Wright, A, Kendrick, E & Slater, P 2016, 'Investigation into the effect on structure of oxoanion doping in Na M(SO ) ·2H O', Journal of Solid State Chemistry, vol. 242, no. Part 1, pp. 103-111. https://doi.org/10.1016/j.jssc.2016.07.0042 4 2 2 Link to publication on Research at Birmingham portal Publisher Rights Statement: Checked 7/9/2016 General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication. •Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research. •User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?) •Users may not further distribute the material nor use it for the purposes of commercial gain. Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
    [Show full text]
  • Investigation Into the Effect on Structure of Oxoanion Doping in Na2m(SO4)2·2H2O Driscoll, Laura; Wright, Adrian; Kendrick, Emma; Slater, Peter
    University of Birmingham Investigation into the effect on structure of oxoanion doping in Na2M(SO4)2·2H2O Driscoll, Laura; Wright, Adrian; Kendrick, Emma; Slater, Peter DOI: 10.1016/j.jssc.2016.07.004 License: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) Document Version Peer reviewed version Citation for published version (Harvard): Driscoll, L, Wright, A, Kendrick, E & Slater, P 2016, 'Investigation into the effect on structure of oxoanion doping in Na M(SO ) ·2H O', Journal of Solid State Chemistry, vol. 242, no. Part 1, pp. 103-111. https://doi.org/10.1016/j.jssc.2016.07.0042 4 2 2 Link to publication on Research at Birmingham portal Publisher Rights Statement: Checked 7/9/2016 General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication. •Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research. •User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?) •Users may not further distribute the material nor use it for the purposes of commercial gain. Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
    [Show full text]
  • Potassium Selenate, Sodium Selenate,Sodium Selenite
    26 March 2015 EMA/CVMP/187590/2015 Committee for Medicinal Products for Veterinary Use European public MRL assessment report (EPMAR) Potassium selenate (All food producing species) Sodium selenate (All food producing species) Sodium selenite (All food producing species) Selenate and selenite salts have a widespread prophylactic and therapeutic use in veterinary medicines against diseases and disorders related to selenium deficiencies in animals. The substances were previously evaluated by the Committee for Medicinal Products for Veterinary Use in 1997, leading to the establishment of “No MRL required” classifications in all food producing species with no restrictions on the route of administration1. On 12 May 2014 the European Commission requested the European Medicines Agency to review the established maximum residue limits. This request followed the CVMPs recommendation of 10 April 2014 on barium selenate and focused on concerns relating to potential consumer exposure to residues at the injection site. Based on the available data, the Committee for Medicinal Products for Veterinary Use recommended, on 4 December 2014, the maintenance of the existing MRL classifications for potassium selenate, sodium selenate and sodium selenite in all food producing species. 1 Commission Regulation (EU) No 37/2010, of 22.12.2009 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency of the European Union © European Medicines Agency, 2015. Reproduction is authorised provided the source is acknowledged. Summary of the scientific discussion for the establishment of MRLs Substance name: Potassium selenate, sodium selenate and sodium selenite Therapeutic class: Alimentary tract and metabolism/mineral supplements Procedure number: EMEA/V/MRL/003225/MODF/0002 Applicant: European Commission Target species: All food producing species Intended therapeutic indication: Selenium deficiency Route(s) of administration: Oral/Intramuscular 1.
    [Show full text]
  • California Official Feed Terms
    CALIFORNIA OFFICIAL FEED TERMS Alfalfa Products Barley Products Chopped Alfalfa Ground Barley Alfalfa Meal Rolled Barley Alfalfa Leaf Meal Ground Light Barley Forage Meal Rolled Light Barley Alfalfa Stem Meal Barley Mixed Feed Alfalfa Pellets, Cubes, Wafers Barley Hulls Alfalfa Nutrient Concentrate Barley Feed Concentrated Alfalfa Solubles Hulled Barley Ground Hulled Barley Almond Hull Products Rolled Hull Barley Almond Hulls Almond Hull and Shell Beet Products Almond Shell Dried Beet Pulp Wet Beet Pulp Animal Products Molasses Dried Beet Pulp Meat Meal Molasses Dried Beet Pulp Product Meat and Bone Meal Blood Meal Brewers’ and Distiller’s Products Poultry By-Product Meal Brewers Dried Grains Poultry Hatchery By-Product Brewers Wet Grains Hydrolyzed Poultry Feathers Malt Sprouts Dry Rendered Tankage Malt Cleanings Dried Meat Solubles Malt Hulls Fleshing Hyrdolysate Dried Spent Hops Animal By-Product Meal Molasses Distillers Dried Solubles Hydrolyzed Hair Potato Distillers Dried Residue Hydrolyzed Leather Meal Distillers Dried Solubles Sprayed Dried Animal Blood Distillers Dried Grains Egg Shell Meal Condensed Distillers Solubles Egg Product Poultry Meal Coconut Products Blood Meal, Flash Dried Coconut Meal Glandular Meal and Extracted Glandular Meal Copra Meal Animal Plasma Coconut Meal, Solvent Extracted Ensiled Paunch Product Copra Meal, Solvent Extracted Leather Hydrolyzate Corn Products Processed Animal Waste Products Corn Bran Dried Poultry Waste Corn Feed Meal Dried Poultry Litter Ground Corn Dried Ruminant Waste Corn Meal Processed
    [Show full text]
  • Selenium in Drinking-Water
    WHO/HSE/WSH/10.01/14 Selenium in Drinking-water Background document for development of WHO Guidelines for Drinking-water Quality Selenium in Drinking-water Background document for development of WHO Guidelines for Drinking-water Quality © World Health Organization 2011 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications—whether for sale or for non-commercial distribution—should be addressed to WHO Press at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied.
    [Show full text]
  • FCC 10, Second Supplement the Following Index Is for Convenience and Informational Use Only and Shall Not Be Used for Interpretive Purposes
    Index to FCC 10, Second Supplement The following Index is for convenience and informational use only and shall not be used for interpretive purposes. In addition to effective articles, this Index may also include items recently omitted from the FCC in the indicated Book or Supplement. The monographs and general tests and assay listed in this Index may reference other general test and assay specifications. The articles listed in this Index are not intended to be autonomous standards and should only be interpreted in the context of the entire FCC publication. For the most current version of the FCC please see the FCC Online. Second Supplement, FCC 10 Index / Allura Red AC / I-1 Index Titles of monographs are shown in the boldface type. A 2-Acetylpyrrole, 21 Alcohol, 90%, 1625 2-Acetyl Thiazole, 18 Alcohol, Absolute, 1624 Abbreviations, 7, 3779, 3827 Acetyl Valeryl, 608 Alcohol, Aldehyde-Free, 1625 Absolute Alcohol (Reagent), 5, 3777, Acetyl Value, 1510 Alcohol C-6, 626 3825 Achilleic Acid, 25 Alcohol C-8, 933 Acacia, 602 Acid (Reagent), 5, 3777, 3825 Alcohol C-9, 922 ªAccuracyº, Defined, 1641 Acid-Hydrolyzed Milk Protein, 22 Alcohol C-10, 390 Acesulfame K, 9 Acid-Hydrolyzed Proteins, 22 Alcohol C-11, 1328 Acesulfame Potassium, 9 Acid Calcium Phosphate, 240 Alcohol C-12, 738 Acetal, 10 Acid Hydrolysates of Proteins, 22 Alcohol C-16, 614 Acetaldehyde, 11 Acidic Sodium Aluminum Phosphate, Alcohol Content of Ethyl Oxyhydrate Acetaldehyde Diethyl Acetal, 10 1148 Flavor Chemicals (Other than Acetaldehyde Test Paper, 1636 Acidified Sodium Chlorite
    [Show full text]
  • Food Supplements: Permitted Vitamins and Minerals
    Food Supplements List of Vitamins and Minerals which may be used in the manufacture of food supplements in the EU Digital ISBN 978 0 7504 7646 1 © Crown copyright 2012 WG15822 Important note This document was correct at the time of publishing. The lists of vitamins and minerals permitted for use in food supplements is subject to change. Please ensure you check the European Commission’s website for any amendments to the list (Click here) Vitamins and minerals which may be used in the manufacture of food supplements as permitted by Directive 2002/46/EC relating to food supplements1 Vitamins Unit of Minerals Unit of measurement measurement Vitamin A μg RE Calcium mg Vitamin D μg Magnesium mg Vitamin E mg α-TE Iron mg Vitamin K μg Copper μg Vitamin B1 mg Iodine μg Vitamin B2 mg Zinc mg Niacin mg NE Manganese mg Pantothenic acid mg Sodium mg Vitamin B6 mg Potassium mg Folic acid2 μg Selenium μg Vitamin B12 μg Chromium μg Biotin μg Molybdenum μg Vitamin C mg Fluoride mg Chloride mg Phosphorus mg Boron mg Silicon mg 1 As amended by Regulation (EC) No. 1137/2008 (OJ L311, 21.11.2008, p.1; Regulation (EC) No. 1170/2009 (OJ L314, 1.12.2009, p.36); and Regulation (EC) No. 1161/2011 (OJ L296, 15.11.2011, p.29) 2 Folic acid is the term included in Annex I of Commission Directive 2008/100/EC of 28 October 2008 amending Council Directive 90/496/EEC on nutrition labelling for foodstuffs as regards recommended daily allowances, energy conversion factors and definitions for nutrition labelling purposes and covers all forms of folates." Vitamins VITAMIN
    [Show full text]